Page last updated: 2024-08-25

clarithromycin and Diathesis

clarithromycin has been researched along with Diathesis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	4 (57.14)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buzon, RA; Chupak, L; Dougherty, TJ; Falcone, MJ; Farley, KA; Finegan, SM; Flanagan, ME; Girard, D; Granskog, K; Hagen, AE; Hardink, JR; Huband, MD; Kamicker, BJ; Kaneko, T; Knickerbocker, MJ; Li, B; Liras, JL; Magee, TV; Marra, A; Medina, I; Nguyen, TT; Noe, MC; O'Donnell, JP; Obach, RS; Penzien, JB; Reilly, UD; Ripp, SL; Schafer, JR; Shen, Y; Stone, GG; Strelevitz, TJ; Sun, J; Tait-Kamradt, A; Vaz, AD; Whipple, DA; Widlicka, DW; Wishka, DG; Wolkowski, JP	1
Karmakar, S; Padman, A; Sen, T; Swamy Mane, N	1
Breda, R; Janvier, F; Macnab, C; Rigal, S	1
Ando, T; Ina, K; Kawamura-Sato, K; Kusugami, K; Nobata, K; Ohta, M; Tsuzuki, T	1
Dinari, G; Evans, CT; Niv, Y; Passaro, DJ; Samra, Z; Shmuely, H; Yahav, J	1
Azuma, T; Hirai, M; Ito, S; Ito, Y; Kato, T; Kohli, Y; Kuriyama, M; Miyaji, H; Sato, F; Suto, H; Yamazaki, Y	1
Báñez, F; Biechy, M; Gálvez, E; Salgueró, E	1

Trials

2 trial(s) available for clarithromycin and Diathesis

Article	Year
Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure. Digestive diseases and sciences, 2006, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Biopsy; Cells, Cultured; Clarithromycin; Cohort Studies; Disease Susceptibility; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Stomach; Treatment Failure	2006
Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter pylori; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Outcome	1997

Article

Year

Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure.

Digestive diseases and sciences, 2006, Volume: 51, Issue:12

Topics: Anti-Bacterial Agents; Biopsy; Cells, Cultured; Clarithromycin; Cohort Studies; Disease Susceptibility; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Stomach; Treatment Failure

2006

Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan.

Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:6

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter pylori; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Outcome

1997

Other Studies

5 other study(ies) available for clarithromycin and Diathesis

Article	Year
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections. Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23 Topics: Animals; Azetidines; Bacteria; Community-Acquired Infections; Disease Susceptibility; Drug Discovery; Drug Resistance, Multiple; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Mice; Microbial Sensitivity Tests; Respiratory Tract Infections	2009
Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats. European journal of pharmacology, 2013, Jun-05, Volume: 709, Issue:1-3 Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Dietary Supplements; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Electrocardiography; Electrolytes; Furosemide; Heart; Hypokalemia; Male; Potassium, Dietary; Rats; Rats, Wistar; Risk Factors; Severity of Illness Index; Suspensions	2013
[Mycobacterium massiliense bone infection]. Medecine et maladies infectieuses, 2012, Volume: 42, Issue:1 Topics: Cicatrix; Clarithromycin; Debridement; Diabetes Mellitus, Type 2; Disease Susceptibility; Femoral Fractures; Fracture Fixation, Internal; Fractures, Closed; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Osteomyelitis; Osteotomy; Ribotyping; Rifampin; Surgical Wound Infection; Vancomycin	2012
Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:7 Topics: Anti-Bacterial Agents; Binding, Competitive; Clarithromycin; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Epithelial Cells; Gastric Mucosa; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Stomach; Treatment Outcome; Urease	2002
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6 Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh	2001